** Shares of life sciences firms Thermo Fisher Scientific TMO.N and Danaher DHR.N rise over 2% in premarket trade
** Franco-German peer Sartorius' SATG.DE Q4 orders in its key bioprocess solutions division (BPS) rose 23.1% to 856.7 million euros
** SATG also reports annual underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of 945 mln euros ($984.78 mln), topping a Vara consensus estimate of 932.7 mln
** With the significant orders beat and another quarter of sequential BPS order improvement, we view the SATG results as a positive data point for AVTR, DHR and TMO, and expect the group to trade well - brokerage Citi Research
** Shares of Avantor AVTR.N were up marginally premarket
** In 2024, AVTR fell 7.7%, DHR fell 0.8% and TMO fell 2%
($1 = 0.9596 euros)
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。